Wertpapierdatensatz · archiviertes Quartal
AVXL
Anavex Life Sciences Corp. · Healthcare · Biotechnology
14Erfasste Halter
0Δ Inhaber
20.35MGehaltene Aktien
$181.11MGemeldeter Wert
+0Neue Positionen
−0Ausstiege
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +2.9% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 31.52M | $81.72M | +7 | −8 |
| Q1 2026 | 83 | +4 | 34.46M | $105.82M | +13 | −9 |
| Q4 2025 | 79 | +2 | 31.53M | $112.26M | +2 | — |
| Q3 2025 | 14 | 0 | 20.35M | $181.11M | — | — |
| Q2 2025 | 11 | -2 | 18.83M | $173.63M | — | −2 |
| Q1 2025 | 10 | -1 | 6.83M | $58.56M | — | −1 |
| Q4 2024 | 11 | +3 | 6.21M | $66.68M | +3 | — |
| Q3 2024 | 7 | -2 | 3.52M | $20.02M | — | −2 |
| Q2 2024 | 9 | — | 3.99M | $16.85M | — | — |
Wer es hält · Q3 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passiv) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passiv) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passiv) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passiv) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passiv) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passiv) | 3.29M | +11.5% | $29.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passiv) | 2.03M | +0.4% | $18.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passiv) | 2.03M | +0.4% | $18.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 1.04M | +6.5% | $9.23M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 560.15K | — | $4.99M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 560.15K | — | $4.99M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 560.15K | — | $4.99M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 560.15K | — | $4.99M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 560.15K | — | $4.99M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Goldman Sachs Group ✦ | 303.39K | — | $2.70M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 303.39K | — | $2.70M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Wellington Management ✦ | 288.81K | +48.2% | $2.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 29 | Wellington Management ✦ | 288.81K | +48.2% | $2.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | Wellington Management ✦ | 288.81K | +48.2% | $2.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 195.72K | -39.2% | $1.74M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 195.72K | -39.2% | $1.74M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 33 | Marshall Wace ✦ | 182.19K | 0.0% | $1.62M | 0.0% | Held | 4 | SEC ↗ |
| 34 | Marshall Wace ✦ | 182.19K | 0.0% | $1.62M | 0.0% | Held | 4 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 90.13K | — | $802,158 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | T. Rowe Price ✦ | 45.61K | +9.2% | $406,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 28.04K | -3.5% | $249,517 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 28.04K | -3.5% | $249,517 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 28.04K | -3.5% | $249,517 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 28.04K | -3.5% | $249,517 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | Fidelity (FMR) ✦ | 10.61K | +1.9% | $94,380 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 49 | Fidelity (FMR) ✦ | 10.61K | +1.9% | $94,380 | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 39.00K Anteile, $119 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q3 2025 ·
Methodik ·
Über die API abrufen